Goldman dialed back its recession call on Wednesday just an hour after raising the odds in an earlier note, as the trade war ...

Goldman Sachs Group Inc. economists said they now see a 65% chance of a US recession in the next 12 months, citing President ...

A tariff-driven recession is the "likely outcome" for the U.S. economy, says Jamie Dimon, the head of the country's largest ...

Last time I wrote about Goldman Sachs, my rating was a sell. Check out why I maintain my sell rating on GS stock.

Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of p15,318.00.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In a recent report, investment bank Goldman Sachs & Co. published a list of the stocks with the greatest upside potential.

Continued tariff escalation between the United States and China presents a downside risk to a 2025 full-year real GDP ...

President Donald Trump will place a jarring 104% tariff on Chinese goods, wiping out gains on Wall Street after three chaotic ...

President Donald Trump's wide-ranging "reciprocal" tariffs against U.S. trading partners are scheduled to go into effect at ...

Goldman Sachs forecast that Brent and WTI crude prices would be at $62 a barrel and $58 by December 2025 and at $55 and $51 ...

It was a roller-coaster day in stocks as panic selling subsided, while President Trump threatened to hit China with a 50% ...